Aktuella utlysningar, vecka 9, 2019

Publicerat 2019-02-27 08:27. Uppdaterat 2019-03-06 15:48This page in English

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska utlysningar

Sabbath scholarships – Wenner-Gren Foundations

The Wenner-Gren Foundations invite applications for its Sabbath scholarships. These enable scientist and professors to stay at a foreign scientific institution. Swedish or foreign citizens with permanent residence permits in Sweden may apply. The applicant must have completed a doctoral degree more than five years before the application date. The scholarships are granted for a period of at least three and a maximum of 12 months. Funding covers accommodation costs, health insurance, tuition fees and school fees for children during their stay abroad.

Closing date: 10 March 2019

Sabbath scholarships – Wenner-Gren Foundations 

Bidrag för cancerforskning – Mary Béves Stiftelse för Barncancerforskning

Mary Béves Stiftelse för Barncancerforskning inbjuder ansökningar om bidrag för cancerforskning. Dessa stöder forskning och utveckling av barncancervården och utbyte av information mellan forskare. Både patientnära och experimentell klinisk barnonkologisk forskning stöds. Ansökningar från yngre forskare, disputerade såväl som odisputerade, uppmuntras. Huvudsökande ska ha avlagt doktorsexamen.

Closing date: 11 March 2019

Bidrag för cancerforskning – Mary Béves Stiftelse för Barncancerforskning 

Grants for research and development projects – Stiftelsen Promobilia

The Promobilia Foundation invites applications for its research and development project grants. These promote the development and production of technical aids that enable disabled persons to have a more active life. The foundation mainly supports the development of tools for mobility for disabled persons but may also support research about reading and writing difficulties.

Closing date: 14 March 2019

Grants for research and development projects – Stiftelsen Promobilia 

Postdoc stipendier ur Elisabeth och Alfred Ahlqvists stiftelse – Swedish Pharmaceutical Society

Apotekarsocieteten inbjuder ansökningar om postdoc stipendier ur Elisabeth och Alfred Ahlqvists stiftelse. Dessa främjar grundläggande läkemedelsforskning under ett år vid ett välrenommerat universitet utomlands efter avlagd doktorsexamen. Bidrag kan sökas av enskilda individer. Stipendier ska avse kommande aktiviteter som börjar efter den 1 juni 2019. Medlemmar prioriteras vid likvärdiga ansökningar.

Closing date: 14 March 2019

Postdoc stipendier ur Elisabeth och Alfred Ahlqvists stiftelse – Swedish Pharmaceutical Society 

Forskningsprojekt om ”Det trygga hemmet 2030” – Länsförsäkringars Forskningsfond

Utlysningen fokuserar på hur det allt intelligentare hemmet kan leda till färre skador, ökad upplevd trygghet samt beteendeförändringar. Länsförsäkringar arbetar skadeförebyggande och verkar för ett tryggt och skadefritt liv. Att agera skadeförebyggande är viktigt ur hållbarhetssynpunkt – både socialt, ekonomiskt och miljömässigt. Uppkopplade IoT-enheter, med allt från sensorer till kameror, bildigenkänning och hälsoapparatur, är exempel på tekniska hjälpmedel som troligen blir vanligare och kan bidra till ökad trygghet i hemmet.

Closing date: 8 April 2019

Forskningsprojekt om ”Det trygga hemmet 2030” – Länsförsäkringars Forskningsfond 

Planeringsbidrag Horisont 2020 – Swedish Civil Contingencies Agency (Myndigheten för samhällsskydd och beredskap)

Detta bidrag stöder planering av projekt inom EU:s ramprogram för forskning Horisont 2020. Bidrag uppgår till maximalt SEK 150,000 för koordinator och SEK 50,000 för partner.

Closing date: 15 April 2019

Planeringsbidrag Horisont 2020 – Swedish Civil Contingencies Agency (Myndigheten för samhällsskydd och beredskap) 

Industrial PhD student 2019 - The Foundation for Strategic Research (SSF)

SSF allocates SEK 30 million for an investment in doctoral education to a doctor or licentiate in 2019. Each grant within the program covers funding for research and a doctoral education for an industrial doctoral student / industrial license, in collaboration with business and academia. The grant runs for two to five years and will result in a doctoral or a licentiate degree.

Closing date: 23 April 2019

Industrial PhD student 2019 - The Foundation for Strategic Research (SSF) 

Journal of Internal Medicine (JIM) Think Tank

JIM would like to invite researchers to organise a JIM within the area of Internal Medicine. With long experience of successful scientific meetings, JIM now introduces the idea and concept of a JIM Think Tank:

A small meeting - around 10 participants, preferably multinational; The form of the meeting can vary - either virtual or face to face at a suitable venue; Overnight stay, for up to two nights; Funding - up to 25,000 USD; Discussions according to a prescheduled programme - lectures not required; A Think Tank meeting should result in one or two scientific articles for publication in JIM Journal of Internal Medicine, as Reviews, Original Articles or Consensus/Guidelines. There will be additional remuneration for these publications; The organiser of the Think Tank will be appointed as a Guest Editor with responsibility for the writing and submission of the article(s) to JIM, within a set deadline; The JIM Editorial Office can provide administrative support.

Closing date: No deadline

Journal of Internal Medicine (JIM) Think Tank 

Europeiska utlysningar

COMING SOON: ERC-2019-AdG advanced grants -- Horizon 2020: Excellent Science, EU and other funders

These support ground-breaking high-risk projects carried out by an established, leading principal investigator in any field of research. Applicants are expected to be active researchers who have a track-record of significant research achievements in the last 10 years, and should be exceptional leaders in terms of originality and significance of their research contributions.

Approximately 166 grants are available, each worth up to €2.5m, over five years. An additional €1m may be requested.

Deadline information: Proposals are invited between 21 May and 29 August 2019.

COMING SOON: ERC-2019-AdG advanced grants -- Horizon 2020: Excellent Science, EU and other funders 

Research fellowship -- European Academy of Dermatology and Venereology, EUR

This enables young scientists to receive advanced training on basic or clinical research in dermatology or venereology in a high standard clinical or research centre at a country other than their own. Applicants must come from Europe, be under 40 years of age and have previous published experience in the field of research they are planning to engage in or have a track record in skin research documented by their publication records.

Fellowships are worth up to €30,000 each over 12 months and cover travel, insurance costs and living expenses.

Closing date: 30 April 2019 (Forecast). Deadline information: We have no information from the funder yet about the next call. Based on past experience, we forecast the deadline to be around April 2019. This call is repeated once a year.

Research fellowship -- European Academy of Dermatology and Venereology, EUR 

Urology scholarships -- European Association of Urology, EUR

These support basic urology research at a European research institution for one year.

Applicants must be under 40 years of age, be urologists or urologists-in-training and be members of EAU. Applicants must have acquired a letter of acceptance from the chairman or programme director of the host institution.

The scholarship is worth up to €30,000 for each project, covering living costs, travel expenses and one round trip ticket.

Closing date: 1 May 2019

Urology scholarships -- European Association of Urology, EUR 

Pilot grants -- Bowel Cancer UK, GB

These enable researchers in the area of bowel cancer to obtain preliminary data for a larger grant application. The pilot study should be designed to obtain information about whether a full-scale study would be feasible. Projects may align with the following areas:

•improving bowel cancer screening;

•understanding and identifying people at high risk of bowel cancer;

•understanding bowel cancer in people below 50 years of age.

Principal applicants must be based at host institutions in the UK, though co-applicants and collaborators may be based at non-UK institutions. Grants are worth up to £25,000 each for up to 18 months

Closing date: 2 May 2019

Pilot grants -- Bowel Cancer UK, GB 

Translational research fellowships -- European Society for Medical Oncology, EUR

These enable young researchers to train in translational research at European institutions of excellence, and to develop specific high-quality translational research projects in oncology.

Applicants must be ESMO members, 40 years of age or under, and oncologists with at least one-year experience in medical, radiation or surgical oncology and currently engaged in cancer research or clinical oncology practice.

Fellowships are worth €40,000 for one year, with the possibility of an additional €40,000 for a second year.

Closing date: 3 May 2019 (Forecast). Deadline information: We have no information from the funder yet about the next call. Based on past experience, we forecast the deadline to be around May 2019. This call is repeated once a year.

Translational research fellowships -- European Society for Medical Oncology, EUR 

Amerikanska utlysningar

Federal Funding agencies

Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed, R21): NIH

The National Institute of Environmental Health Sciences invites applications for its functional RNA modifications environment and disease (R01 clinical trial not allowed) funding opportunity. This supports innovative, mechanistic research focused on how environmental exposures are associated and involved with the functional activities of RNA modifications and pathways that may be modified or misregulated, associated with adverse health outcomes or be useful as biomarkers of exposure or exposure-induced pathologies. The NIEHS will use the R01 mechanism to support hypothesis driven research using approaches that incorporate principles of toxicology with RNA modification biological and/or chemical expertise and utilizes state of the art technologies. The NIEHS will use the R21 mechanism to support innovative, high risk, high reward research addressing how environmental exposures impact this layer of cellular regulation.

Closing date: May 16, 2019 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-ES-19-001 (R01), RFA-ES-19-002 (R21)

Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed): NIH

Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed): NIH 

 

Foundation

Bill and Melinda Gates Foundation, US

Environmental niches of Salmonella Typhi

The Bill and Melinda Gates Foundation invites proposals for its call on environmental niches of Salmonella Typhi. This supports research examining the environmental niches of Salmonella Typhi. Proposals must address:

  • survival of S. Typhi in the context of the soil and water microbiomes;
  • survival of S. Typhi within other organisms;
  • impact of environmental niches on the development of antibiotic resistance in S. Typhi.

Closing date: 10 April 2019 - 11:30AM PDT (Pacific Daylight Time)

Environmental niches of Salmonella Typhi

Emerging Technologies for New Solutions in Global Health Priority Areas

The Bill and Melinda Gates foundation invites proposals for its call on emerging technologies for new solutions in global health priority areas. This supports projects applying emerging technologies to develop new and transformative solutions in global health priority areas. Priority outcome areas encompass the fields of infectious diseases, pregnancy and birth, child growth and development, disease surveillance, and research for the development of new vaccines, drugs and diagnostics. Priority is given to approaches that:

represent potentially transformative approaches that would not have been funded by mechanisms focusing on individual technologies or subject areas;
represent new perspectives on the targeted problem, including applying insights from fields outside of the priority global health areas;
leverage existing data or biosamples from human cohorts or biorepositories of proven value.

Closing date: 10 April 2019 - 11:30AM PDT (Pacific Daylight Time)

Emerging Technologies for New Solutions in Global Health Priority Areas 

Increasing demand for vaccination services

The Bill and Melinda Gates Foundation invites proposals for its call on increasing demand for vaccination services. This supports projects aiming to increase demand for vaccination services, thereby increasing the number of children vaccinated globally. Proposals should relate to one or both of the following specific areas:

novel approaches for providing practical knowledge about vaccines and vaccination;
novel ideas for improving convenience for caregivers seeking vaccination services.

Closing date: 10 April 2019 - 11:30AM PDT (Pacific Daylight Time)

Increasing demand for vaccination services 

Alzheimer's Association, US

Alzheimer's Association Research Grant (AARG)

The purpose of this program is to provide newly independent investigators with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to federal or other funding entities.
Eligibility: Applicants must be Assistant Professors or above at their respective institution and have less than 10 years of research experience after receipt of their terminal degree (doctorate or post residency (MD or DO). Postdoctoral fellows and other junior faculty members (for example: Instructor, Research Associate Scientist, Lecturer, etc.) need to provide a letter of employment verification indicating they will have a full-time faculty position of an Assistant Professor and above by the award date should the proposal be in funding range and funded.

Closing date: March 8, 2019 by 5 p.m. EST (LOI); April 29, 2019 by 5 p.m. EST, (Full-application)

Alzheimer's Association Research Grant (AARG)

Alzheimer’s Association Research Fellowship (AARF)

The Alzheimer’s Association Research Fellowship Award Program is up to three years (minimum 2 years) intended to support exceptional researchers who are engaged in their post-graduate work (i.e. postdoctoral fellows) and before they have their first independent faculty positions (i.e. Assistant Professor) and working in diverse areas of research, including basic, translational, clinical, functional and social-behavioral research.
Eligibility: Postdoctoral fellows with full time positions at their respective institution who have less than 10 years of research experience after receipt of their doctorate or other terminal degree. Individuals who have a position of an Assistant Professorship or above are not eligible.

Closing date: March 8, 2019 by 5 p.m. EST (LOI); April 29, 2019 by 5 p.m. EST, (Full-application)

Alzheimer’s Association Research Fellowship (AARF)

Alzheimer's Drug Discovery Foundation, US

NEUROIMAGING AND CSF BIOMARKER DEVELOPMENT PROGRAM

This funding opportunity seeks to support the development of Cerebrospinal fluid (CSF) and neuroimaging biomarkers for multiple contexts of use (see below) that include but are not limited to: 1. Clearly demonstrate target engagement for novel therapeutics. 2. Detect signs of disease earlier and monitor progression. 3. More accurately diagnose and distinguish between dementia subtypes.
Novel biomarkers of neuroinflammation and synaptic integrity are considered high priority. Other target areas of interest include, but are not limited to: Neurodegeneration, Vascular injury or blood-brain barrier integrity, Mitochondria & metabolic function, Protein misfolding/proteostasis, Oxidative stress, White matter changes.
All proposals should address the following: ● Potential for Commercial Translation, ● Context of Use, ● How the Proposed Biomarker Compares to Currently Available Biomarkers. Industry partnerships are strongly encouraged.
Average Duration: One year with potential for follow-on funding. Multi-year proposals can be considered.
Average Award: $150,000-$600,000 based on stage and scope of research. Larger amounts will be considered for PET ligand development for regulatory or clinical work. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Closing date: April 12, 2019 by 5:00 pm ET, (LOI); May 10, 2019 by 5:00 pm ET, (Invited Full Proposal)

NEUROIMAGING AND CSF BIOMARKER DEVELOPMENT PROGRAM

Programme to accelerate clinical trials (PACT)

The goal of this funding opportunity is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer's disease and related dementias. The funding opportunity supports clinical trials, experimental medicine, and regulatory studies for novel drugs (small molecules and biologics including antibodies, peptides, gene therapies), repurposed drugs (existing drugs that are approved for other diseases and conditions), repositioned drugs (existing drugs that have entered clinical trials for other indications and have not yet been approved), and natural products. Special interest in: ● Early-stage human clinical trials, ● Regulatory studies.
Examples for Drug Targets and target areas of interest: Neuroprotection, Inflammation, Vascular function, Mitochondria & metabolic function, Proteostasis, ApoE, Epigenetics, Synaptic activity and neurotransmitters, Other aging targets (e.g. senescent cells).

Average Duration: Varies (multi-year) with potential for follow-on funding.

Average Award: Up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Closing date: April 12, 2019 by 5:00 pm ET, (LOI); May 10, 2019 by 5:00 pm ET, (Invited Full Proposal)

Programme to accelerate clinical trials (PACT) 

Prevention beyond the pipeline

This funding opportunity seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.
Average Duration: One year for epidemiological analyses. Varies (multi-year) for clinical trials
Average Award: $50,000-$100,000 for epidemiological analyses based on scope of research. Up to $3 million for clinical trials based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Closing date: April 12, 2019 by 5:00 pm ET, (LOI); May 10, 2019 by 5:00 pm ET, (Invited Full Proposal)

Prevention beyond the pipeline 

Länkar